Announcements Trials
Browse Landscape

Phase

Phase 4 8Phase 2 6Phase 3 3Phase NA 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Cancer 1Pancreatic Neoplasms 1Malignant Neoplasms of Female Genital Organs 1

Interventions

Cisplatin 187Carboplatin 182Paclitaxel 178Docetaxel 146Cyclophosphamide 129Dexamethasone 118pembrolizumab 106Bevacizumab 104Doxorubicin 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 82Radiotherapy 77Vincristine 71Etoposide 71Nivolumab 69Capecitabine 69Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 48Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Has results × Bupivacaine × Clear all
NCT03434678 2025-07-30

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
133 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03359811 2022-02-18

Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Completed
75 enrolled 21 charts

Peritoneal Cancer

NCT02740114 2021-10-18

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Terminated
105 enrolled 9 charts
GynecologicOther neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡